SCHEMBL17658772

SCHEMBL17658772

COc1ccc(OCCOCCOc2ccc(C=O)nc2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
FDPS P14324 1/20 0.41
MAPT P10636 3/20 0.40
HPGD P15428 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KDM4E B2RXH2 1/20 0.38
LMNA P02545 2/20 0.38
ERN1 O75460 3/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNA4 P43681 1/20 0.38
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
ALOX12 P18054 1/20 0.36
MAPK1 P28482 1/20 0.36
RECQL P46063 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17662278 0.88 ALDH1A1 (0.43) ALDH1A1FDPSMAPTHPGDCYP1A2
SCHEMBL20489803 0.84 ALDH1A1 (0.42) ALDH1A1FDPSMAPTHPGDKDM4E
SCHEMBL29417205 0.84 ALDH1A1 (0.42) ALDH1A1FDPSMAPTHPGDKDM4E
SCHEMBL27028897 0.84 ALDH1A1 (0.42) ALDH1A1MAPTHPGDKDM4ELMNA
SCHEMBL30598771 0.84 ALDH1A1 (0.42) ALDH1A1MAPTHPGDKDM4ELMNA
SCHEMBL20489792 0.82 NCF1 (0.42) ALDH1A1FDPSMAPTHPGDCYP1A2
SCHEMBL31371078 0.82 FDPS (0.40) ALDH1A1FDPSMAPTHPGDKDM4E
SCHEMBL17941786 0.81 APP (0.44) ALDH1A1MAPT
SCHEMBL7373164 0.77 CA12 (0.42) ALDH1A1MAPTHPGDCYP2C9LMNA
SCHEMBL8522859 0.77 MAPT (0.44) ALDH1A1MAPTHPGDCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160096820-A1 INHIBITORS OF INV(16) LEUKEMIA UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2016-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160096820-A1 INHIBITORS OF INV(16) LEUKEMIA FLI1, MCL1, CBFB ALDH1A1 4339/4885FDPS 3678/4885MAPT 2247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.